Detailed Information
Cited 37 time in 
Cited 39 time in 
Cited 39 time in
Metadata Downloads
Dapagliflozin as add-on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial
- Authors
- Yang, WY[Yang, Wenying]; Ma, JH[Ma, Jianhua]; Li, YM[Li, Yiming]; Li, YB[Li, Yanbing]; Zhou, ZG[Zhou, Zhiguang]; Kim, JH[Kim, Jae Hyeon]; Zhao, J[Zhao, June]; Ptaszynska, A[Ptaszynska, Agata]
- Issue Date
- Jul-2018
- Publisher
- WILEY
- Keywords
- Asian; dapagliflozin; insulin; type 2 diabetes
- Citation
- JOURNAL OF DIABETES, v.10, no.7, pp.589 - 599
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF DIABETES
- Volume
- 10
- Number
- 7
- Start Page
- 589
- End Page
- 599
- ISSN
- 1753-0393
- Abstract
- Background: This 24-week Phase 3 double-blind placebo-controlled study assessed the safety and efficacy of dapagliflozin as add-on to insulin, with or without oral antihyperglycemic drugs (OADs), in Asian patients with inadequately controlled type 2 diabetes mellitus.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.